Treatment with anti-ErbB2 antibodies | Patent Number 08425908

US 08425908 B2
Application Number13185329
Publication NumberUS 20120034213 A1
Pendency1 year, 9 months, 10 days
Filled DateJul 18, 2011
Priority DateDec 12, 1997
Publication DateFeb 9, 2012
Expiration DateApr 23, 2021
Inventor/ApplicantsSusan D. Hellmann
ExaminesHOLLERAN, ANNE L
Art Unit1643
Technology Center1600
Assignments
Roche
Current
Genentech IncRoche
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.